Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 67

1.

Low-frequency electrical stimulation with variable intensity preserves torque.

Mettler JA, Magee DM, Doucet BM.

J Electromyogr Kinesiol. 2018 Oct;42:49-56. doi: 10.1016/j.jelekin.2018.06.007. Epub 2018 Jun 18.

PMID:
29945028
2.

High-Frequency Neuromuscular Electrical Stimulation Increases Anabolic Signaling.

Mettler JA, Magee DM, Doucet BM.

Med Sci Sports Exerc. 2018 Aug;50(8):1540-1548. doi: 10.1249/MSS.0000000000001610.

PMID:
29554013
3.

Proteogenomic Re-Annotation of Coccidioides posadasii Strain Silveira.

Mitchell NM, Sherrard AL, Dasari S, Magee DM, Grys TE, Lake DF.

Proteomics. 2018 Jan;18(1). doi: 10.1002/pmic.201700173. Epub 2017 Dec 14.

PMID:
29130603
4.

Automatic Identification and Quantification of Extra-Well Fluorescence in Microarray Images.

Rivera R, Wang J, Yu X, Demirkan G, Hopper M, Bian X, Tahsin T, Magee DM, Qiu J, LaBaer J, Wallstrom G.

J Proteome Res. 2017 Nov 3;16(11):3969-3977. doi: 10.1021/acs.jproteome.7b00267. Epub 2017 Oct 10.

PMID:
28938071
5.

Neuromuscular Electrical Stimulation and Anabolic Signaling in Patients with Stroke.

Mettler JA, Bennett SM, Doucet BM, Magee DM.

J Stroke Cerebrovasc Dis. 2017 Dec;26(12):2954-2963. doi: 10.1016/j.jstrokecerebrovasdis.2017.07.019. Epub 2017 Aug 16.

PMID:
28823492
6.

Interleukin-17A Promotes Lung Tumor Progression through Neutrophil Attraction to Tumor Sites and Mediating Resistance to PD-1 Blockade.

Akbay EA, Koyama S, Liu Y, Dries R, Bufe LE, Silkes M, Alam MM, Magee DM, Jones R, Jinushi M, Kulkarni M, Carretero J, Wang X, Warner-Hatten T, Cavanaugh JD, Osa A, Kumanogoh A, Freeman GJ, Awad MM, Christiani DC, Bueno R, Hammerman PS, Dranoff G, Wong KK.

J Thorac Oncol. 2017 Aug;12(8):1268-1279. doi: 10.1016/j.jtho.2017.04.017. Epub 2017 May 6.

7.

Identification of Antibody Targets for Tuberculosis Serology using High-Density Nucleic Acid Programmable Protein Arrays.

Song L, Wallstrom G, Yu X, Hopper M, Van Duine J, Steel J, Park J, Wiktor P, Kahn P, Brunner A, Wilson D, Jenny-Avital ER, Qiu J, Labaer J, Magee DM, Achkar JM.

Mol Cell Proteomics. 2017 Apr;16(4 suppl 1):S277-S289. doi: 10.1074/mcp.M116.065953. Epub 2017 Feb 21.

8.

Total and Lectin-Binding Proteome of Spherulin from Coccidioides posadasii.

Grys TE, Kaushal S, Chowdhury Y, Dasari S, Mitchell NM, Magee DM, Blair JE, Colby TV, Lake DF.

J Proteome Res. 2016 Oct 7;15(10):3463-3472. Epub 2016 Aug 29.

PMID:
27546806
9.

Mycobacterial membrane vesicles administered systemically in mice induce a protective immune response to surface compartments of Mycobacterium tuberculosis.

Prados-Rosales R, CarreƱo LJ, Batista-Gonzalez A, Baena A, Venkataswamy MM, Xu J, Yu X, Wallstrom G, Magee DM, LaBaer J, Achkar JM, Jacobs WR Jr, Chan J, Porcelli SA, Casadevall A.

MBio. 2014 Sep 30;5(5):e01921-14. doi: 10.1128/mBio.01921-14.

10.

Application of immunosignatures for diagnosis of valley fever.

Navalkar KA, Johnston SA, Woodbury N, Galgiani JN, Magee DM, Chicacz Z, Stafford P.

Clin Vaccine Immunol. 2014 Aug;21(8):1169-77. doi: 10.1128/CVI.00228-14. Epub 2014 Jun 25.

11.

Quantifying antibody binding on protein microarrays using microarray nonlinear calibration.

Yu X, Wallstrom G, Magee DM, Qiu J, Mendoza DE, Wang J, Bian X, Graves M, LaBaer J.

Biotechniques. 2013 May;54(5):257-64. doi: 10.2144/000114028.

12.

Emerging protein array technologies for proteomics.

Lee JR, Magee DM, Gaster RS, LaBaer J, Wang SX.

Expert Rev Proteomics. 2013 Feb;10(1):65-75. doi: 10.1586/epr.12.67. Review.

13.

High density diffusion-free nanowell arrays.

Takulapalli BR, Qiu J, Magee DM, Kahn P, Brunner A, Barker K, Means S, Miersch S, Bian X, Mendoza A, Festa F, Syal K, Park JG, LaBaer J, Wiktor P.

J Proteome Res. 2012 Aug 3;11(8):4382-91. doi: 10.1021/pr300467q. Epub 2012 Jul 13.

14.

Physical characterization of the "immunosignaturing effect".

Stafford P, Halperin R, Legutki JB, Magee DM, Galgiani J, Johnston SA.

Mol Cell Proteomics. 2012 Apr;11(4):M111.011593. doi: 10.1074/mcp.M111.011593. Epub 2012 Jan 18.

15.

Application of immunosignatures to the assessment of Alzheimer's disease.

Restrepo L, Stafford P, Magee DM, Johnston SA.

Ann Neurol. 2011 Aug;70(2):286-95. doi: 10.1002/ana.22405.

PMID:
21823156
16.

Extended safety and efficacy studies of a live attenuated double leucine and pantothenate auxotroph of Mycobacterium tuberculosis as a vaccine candidate.

Sampson SL, Mansfield KG, Carville A, Magee DM, Quitugua T, Howerth EW, Bloom BR, Hondalus MK.

Vaccine. 2011 Jun 24;29(29-30):4839-47. doi: 10.1016/j.vaccine.2011.04.066. Epub 2011 May 5.

17.

A general method for characterization of humoral immunity induced by a vaccine or infection.

Legutki JB, Magee DM, Stafford P, Johnston SA.

Vaccine. 2010 Jun 17;28(28):4529-37. doi: 10.1016/j.vaccine.2010.04.061. Epub 2010 May 5.

PMID:
20450869
18.

New classes of orthopoxvirus vaccine candidates by functionally screening a synthetic library for protective antigens.

Borovkov A, Magee DM, Loskutov A, Cano JA, Selinsky C, Zsemlye J, Lyons CR, Sykes K.

Virology. 2009 Dec 5;395(1):97-113. doi: 10.1016/j.virol.2009.09.008. Epub 2009 Oct 2.

19.

Role of B cells in vaccine-induced immunity against coccidioidomycosis.

Magee DM, Friedberg RL, Woitaske MD, Johnston SA, Cox RA.

Infect Immun. 2005 Oct;73(10):7011-3.

20.
22.
23.

Coccidioidomycosis: host response and vaccine development.

Cox RA, Magee DM.

Clin Microbiol Rev. 2004 Oct;17(4):804-39, table of contents. Review.

24.

PAM14, a novel MRG- and Rb-associated protein, is not required for development and T-cell function in mice.

Tominaga K, Magee DM, Matzuk MM, Pereira-Smith OM.

Mol Cell Biol. 2004 Oct;24(19):8366-73.

25.

Identification of a protective antigen of Coccidioides immitis by expression library immunization.

Ivey FD, Magee DM, Woitaske MD, Johnston SA, Cox RA.

Vaccine. 2003 Oct 1;21(27-30):4359-67.

PMID:
14505918
26.

Transmission of drug-resistant tuberculosis in Texas and Mexico.

Quitugua TN, Seaworth BJ, Weis SE, Taylor JP, Gillette JS, Rosas II, Jost KC Jr, Magee DM, Cox RA.

J Clin Microbiol. 2002 Aug;40(8):2716-24.

27.

Role of signal sequence in vaccine-induced protection against experimental coccidioidomycosis.

Jiang C, Magee DM, Ivey FD, Cox RA.

Infect Immun. 2002 Jul;70(7):3539-45.

30.
31.

Protective immunity in coccidioidomycosis.

Cox RA, Magee DM.

Res Immunol. 1998 May-Jun;149(4-5):417-28; discussion 506-7. Review. No abstract available.

PMID:
9720959
32.
33.
35.

Coccidioides immitis antigen 2: analysis of gene and protein.

Zhu Y, Yang C, Magee DM, Cox RA.

Gene. 1996 Nov 28;181(1-2):121-5.

PMID:
8973319
36.
37.

Molecular cloning and characterization of Coccidioides immitis antigen 2 cDNA.

Zhu Y, Yang C, Magee DM, Cox RA.

Infect Immun. 1996 Jul;64(7):2695-9.

38.
41.

Role of CD8 T cells in primary Chlamydia infection.

Magee DM, Williams DM, Smith JG, Bleicker CA, Grubbs BG, Schachter J, Rank RG.

Infect Immun. 1995 Feb;63(2):516-21.

42.

Role for CD8+ T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones.

Igietseme JU, Magee DM, Williams DM, Rank RG.

Infect Immun. 1994 Nov;62(11):5195-7.

43.

Cytokine induction in human coccidioidomycosis.

Dooley DP, Cox RA, Hestilow KL, Dolan MJ, Magee DM.

Infect Immun. 1994 Sep;62(9):3980-3.

44.

Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone.

Igietseme JU, Ramsey KH, Magee DM, Williams DM, Kincy TJ, Rank RG.

Reg Immunol. 1993 Nov-Dec;5(6):317-24.

PMID:
8068534
45.

Chlamydia trachomatis pneumonia in the severe combined immunodeficiency (SCID) mouse.

Magee DM, Igietseme JU, Smith JG, Bleicker CA, Grubbs BG, Schachter J, Rank RG, Williams DM.

Reg Immunol. 1993 Nov-Dec;5(6):305-11.

PMID:
7520728
46.

Gamma interferon levels during Chlamydia trachomatis pneumonia in mice.

Williams DM, Grubbs BG, Schachter J, Magee DM.

Infect Immun. 1993 Aug;61(8):3556-8.

47.

Induction of tumor necrosis factor-alpha in murine Candida albicans infection.

Allendoerfer R, Magee DM, Smith JG, Bonewald L, Graybill JR.

J Infect Dis. 1993 May;167(5):1168-72.

PMID:
8486950
48.
49.

Transfer of protective immunity in murine histoplasmosis by a CD4+ T-cell clone.

Allendoerfer R, Magee DM, Deepe GS Jr, Graybill JR.

Infect Immun. 1993 Feb;61(2):714-8.

50.

Chlamydia trachomatis pneumonia induces in vivo production of interleukin-1 and -6.

Magee DM, Smith JG, Bleicker CA, Carter CJ, Bonewald LF, Schachter J, Williams DM.

Infect Immun. 1992 Mar;60(3):1217-20.

Supplemental Content

Loading ...
Support Center